Congenital chylothorax treated with oral sildenafil: a case report and review of the literature.
Publication/Presentation Date
5-1-2015
Abstract
Congenital chylothorax (CC) can result from a congenital malformation or an acquired obstruction or disruption of the thoracic duct. Recently, oral administration of the phosphodiesterase-5 inhibitor, sildenafil, was reported to be effective in resolving non-pulmonary lymphatic malformations in infants and young children. We report a case of CC in a late preterm infant with congenital pulmonary lymphangiectasia where octreotide was not effective, but management with oral sildenafil was successful.
Volume
35
Issue
5
First Page
384
Last Page
386
ISSN
1476-5543
Published In/Presented At
Malleske, D. T., & Yoder, B. A. (2015). Congenital chylothorax treated with oral sildenafil: a case report and review of the literature. Journal of perinatology : official journal of the California Perinatal Association, 35(5), 384–386. https://doi.org/10.1038/jp.2015.10
Disciplines
Medicine and Health Sciences | Pediatrics
PubMedID
25917021
Department(s)
Department of Medicine
Document Type
Article
